Sei Investments Co. Decreases Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Sei Investments Co. reduced its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 21.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 504,934 shares of the medical instruments supplier’s stock after selling 139,855 shares during the quarter. Sei Investments Co.’s holdings in DENTSPLY SIRONA were worth $9,584,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Nordea Investment Management AB increased its stake in DENTSPLY SIRONA by 245.0% in the 4th quarter. Nordea Investment Management AB now owns 251,556 shares of the medical instruments supplier’s stock worth $4,754,000 after purchasing an additional 178,639 shares during the period. JPMorgan Chase & Co. increased its stake in shares of DENTSPLY SIRONA by 206.3% in the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier’s stock worth $49,990,000 after buying an additional 1,244,326 shares during the period. Bank of New York Mellon Corp raised its holdings in DENTSPLY SIRONA by 27.9% during the 4th quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier’s stock valued at $45,611,000 after buying an additional 523,692 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its position in DENTSPLY SIRONA by 1.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,101,133 shares of the medical instruments supplier’s stock valued at $39,880,000 after buying an additional 35,360 shares during the period. Finally, Barclays PLC grew its holdings in DENTSPLY SIRONA by 21.8% in the 3rd quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier’s stock worth $8,301,000 after acquiring an additional 54,920 shares during the last quarter. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Performance

Shares of XRAY stock opened at $14.93 on Monday. The company has a market capitalization of $2.97 billion, a price-to-earnings ratio of -7.21, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. DENTSPLY SIRONA Inc. has a one year low of $14.78 and a one year high of $33.22. The company’s 50-day moving average is $17.62 and its 200 day moving average is $20.16.

DENTSPLY SIRONA Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be given a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 4.29%. The ex-dividend date of this dividend is Friday, March 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -14.07%.

Insider Buying and Selling

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 15,142 shares of DENTSPLY SIRONA stock in a transaction on Monday, March 3rd. The stock was acquired at an average price of $16.51 per share, with a total value of $249,994.42. Following the acquisition, the director now owns 81,971 shares in the company, valued at approximately $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.52% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the company. Needham & Company LLC reissued a “hold” rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. UBS Group reduced their target price on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a research note on Tuesday, December 3rd. Morgan Stanley dropped their price target on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating for the company in a research note on Tuesday, December 17th. Evercore ISI reissued an “in-line” rating and set a $20.00 price objective on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Finally, Robert W. Baird dropped their target price on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a research report on Friday, February 28th. Twelve investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $23.33.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.